- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Ulcerative colitis
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 883KB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 144KB)
Etrasimod – March 2024
Etrasimod: Tablet 2 mg; Velsipity®
Last updated
30 May 2025